Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Chimerix Inc (NQ: CMRX )

7.770 USD UNCHANGED
Streaming Delayed Price Updated: 4:42 PM EDT, Apr 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Chimerix Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Chimerix Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021
From GlobeNewswire News Releases
Thinking about buying stock in O-I Glass, 9 Meters Biopharma, Chimerix, Diana Shipping, or Esports Entertainment?
InvestorsObserver issues critical PriceWatch Alerts for OI, NMTR, CMRX, DSX, and GMBL. 
From PR Newswire
Chimerix to Present at Virtual H.C. Wainwright Global Life Sciences Conference
From GlobeNewswire News Releases
Chimerix, Exclusive Worldwide Licensee of Cantex's Investigational Product, DSTAT, Has Announced Promising Topline Results from the First Cohort of a Randomized COVID-19 Clinical Trial
Cantex Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing proprietary pharmaceuticals for the treatment of inflammatory lung diseases and cancer, today announced that... 
From PR Newswire
Chimerix Reports Promising Topline Results from First Cohort of a Randomized COVID-19 Trial with DSTAT
From GlobeNewswire News Releases
Chimerix Reports Fourth Quarter and Year End 2020 Financial Results and Provides Operational Update
From GlobeNewswire News Releases
Chimerix to Report Fourth Quarter and Year End 2020 Financial Results and Provide an Operational Update on February 25, 2021
From GlobeNewswire News Releases
Chimerix Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
From GlobeNewswire News Releases
Chimerix Announces Pricing of Public Offering of Common Stock
From GlobeNewswire News Releases
Chimerix Announces Proposed $75,000,000 Public Offering of Common Stock
From GlobeNewswire News Releases
Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program
From GlobeNewswire News Releases
Chimerix to Present at Virtual H.C. Wainwright BioConnect 2021 Conference
From GlobeNewswire News Releases
Chimerix Announces FDA Acceptance of New Drug Application for Brincidofovir as a Medical Countermeasure for Smallpox
FDA Grants Priority Review and Sets PDUFA Date for April 7, 2021 
From GlobeNewswire News Releases
Chimerix to Present at Credit Suisse 29th Annual Healthcare Conference
From GlobeNewswire News Releases
Chimerix Reports Third Quarter 2020 Financial Results and Provides Operational Update
From GlobeNewswire News Releases
Chimerix to Report Third Quarter 2020 Financial Results and Provide an Operational Update on November 5, 2020
From GlobeNewswire News Releases
Noveome Biotherapeutics, Inc. Announces New Appointments to its Board of Directors
Noveome Biotherapeutics, Inc., a clinical stage biopharmaceutical company focused on developing next-generation biologics for the restoration of cellular integrity of damaged tissues, has appointed M.... 
From Business Wire News Releases
Chimerix to Participate in Upcoming Investor Conferences
From GlobeNewswire News Releases
Chimerix Reports Second Quarter 2020 Financial Results and Provides Operational Update
From GlobeNewswire News Releases
Chimerix to Report Second Quarter 2020 Financial Results and Provide an Operational Update on August 10, 2020
From GlobeNewswire News Releases
Chimerix Appoints Allen Melemed, M.D. as Chief Medical Officer
Former Eli Lilly Veteran Brings Deep Oncology Clinical and Regulatory Expertise 
From GlobeNewswire News Releases
Chimerix to Present at H.C. Wainwright Virtual Fireside Chat Series
From GlobeNewswire News Releases
Chimerix to Present at Jefferies Virtual Healthcare Conference
From GlobeNewswire News Releases
AskBio Announces Appointment of Tim Trost as Chief Financial Officer
From GlobeNewswire News Releases
Chimerix Reports First Quarter 2020 Financial Results and Provides Operational Update
DSTAT Explored as a Potential Novel Treatment for the Current Pandemic While an NDA is Being Prepared for Brincidofovir to Address a Potential Future Pandemic 
From GlobeNewswire News Releases
Thinking about buying stock in Centennial Resource Development, Chimerix, TherapeuticsMD, Pennsylvania Real Estate, or American Airlines?
InvestorsObserver issues critical PriceWatch Alerts for CDEV, CMRX, TXMD, PEI, and AAL. 
From PR Newswire
Chimerix Announces Initiation of a Phase 2/3 Study of DSTAT in Acute Lung Injury for Patients with Severe COVID-19
From GlobeNewswire News Releases
Chimerix Receives FDA Clearance for Rolling Submission of New Drug Application for Brincidofovir as a Medical Countermeasure for Smallpox
From GlobeNewswire News Releases
Chimerix to Present at Cowen and Company 40th Annual Health Care Conference
From GlobeNewswire News Releases
Chimerix Reports Fourth Quarter and Year End 2019 Financial Results and Provides Operational Update
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.